Medicine

DRUG12 trials

Sponsors

Ikejima Kenichi, Kato Kentaro, Okada Morihito, Morihito Okada, Watanabe Akinori

Conditions

Chronic Kidney DiseaseChronic Liver DiseaseColorectal cancer Colon and rectum, adenocarcinomaDepressive DisorderInfluenza InfluenzaMalignant pleural mesothelioma Respiratory Pleura MesotheliomaMigraineNonalcoholic fatty liver disease Nonalcoholic steatohepatit NAFLD NASH type 2 DM

Phase 1

An Investigator-initiated Clinical Trial, First in Human study, with a natural-type micro RNA MIRX002, for patients with malignant pleural mesothelioma

Active, not recruitingJPRN-jRCT2061210058

Okada MorihitoMalignant pleural mesothelioma Respiratory Pleura Mesothelioma

Start: 2021-12-01Target: 18Updated: 2026-06-29

An Investigator-initiated Clinical Trial, First in Human study, wi th a natural-type micro RNA MIRX002, for patients with malignant pleural mesothelioma (MIRX002-01 repeated dose study)

Active, not recruitingJPRN-jRCT2061220015

Morihito OkadaMalignant pleural mesothelioma Respiratory Pleura Mesothelioma

Start: 2022-04-25Target: 18Updated: 2026-06-29

Phase 2

Chemoselection as a strategy for organ preservation in clinical stage II/III ESCC: a phase II study of induction chemotherapy with docetaxel, cisplatin and 5-FU (DCF) followed by chemoradiotherapy.

Active, not recruitingJPRN-jRCTs031180380

Watanabe AkinoriProblem(s) Studied Esophageal squamous cell carcinoma

Start: 2012-07-05Target: 100Updated: 2026-06-29

Navigation surgery using ICG

Active, not recruitingJPRN-jRCTs071180080

Kenji BabaColorectal cancer Colon and rectum, adenocarcinoma

Start: 2019-09-03Target: 114Updated: 2026-06-29

Phase 4

Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure

Chinese PLA General HospitalChronic Liver Disease, Thrombocytopenia; Drugs

Start: 2021-06-06End: 2023-07-31Target: 476Updated: 2022-11-15

Unknown Phase

Renal Sympathetic Denervation in Patients With Chronic Kidney Disease and Resistant Hypertension

The First Affiliated Hospital with Nanjing Medical UniversityChronic Kidney Disease

Start: 2012-11-30End: 2018-04-30Target: 100Updated: 2012-12-03

Pharmacotherapy and Psychotherapy for MDD After Remission on Psychology and Neuroimaging

Nanjing Medical UniversityDepressive Disorder

Start: 2011-01-31End: 2014-12-31Target: 200Updated: 2013-04-15

Effects of azilsartan for coagulatic and fiblinolytic markers in pathients with hypertension

Active, not recruitingJPRN-UMIN000012060

Shosaku Nomurahypertension

Start: 2013-11-01Target: 100Updated: 2026-06-29

Randomized study comparing Baloxavir Marboxil to Peramivir in pediatric patients with Influenza

Active, not recruitingJPRN-jRCT1051180014

Kato KentaroInfluenza Influenza

Start: 2018-12-12Target: 40Updated: 2026-06-29

Dapagliflozin vs vitamin E against NAFLD with type 2 DM

Active, not recruitingJPRN-jRCT1031180386

Ikejima KenichiNonalcoholic fatty liver disease Nonalcoholic steatohepatit NAFLD NASH type 2 DM

Start: 2019-07-11Target: 40Updated: 2026-06-29

A prospective trial of Elobixibat Hydrate

RecruitingJPRN-jRCTs041240187

Tainaka Takahisabiliary atresia jaundice

Start: 2025-02-10Target: 5Updated: 2026-06-29

Combined Effects of Green Light and Transcranial Direct Current Stimulation in Migraine Patients.

RecruitingNCT06943625

Riphah International UniversityMigraine

Start: 2025-04-24End: 2026-04-30Target: 40Updated: 2026-01-05

Related Papers

Effectiveness and risks of dapagliflozin in treatment for metabolic dysfunction-associated steatotic liver disease with type 2 diabetes: a randomized controlled trial

Frontiers in Medicine2025-03-254 citations

Changes in brain functional networks in remitted major depressive disorder: a six-month follow-up study.

2023-08-286 citations